Supplement_Materials_1 – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, Supplement_Materials_1 for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

Reviewer_2_v.1 – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, Reviewer_2_v.1 for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

Reviewer_1_v.1 – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, Reviewer_1_v.1 for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

PRISMA-2009-Flow-Diagram-MS-Word – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, PRISMA-2009-Flow-Diagram-MS-Word for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

PRISMA-2009-Checklist-MS-Word – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, PRISMA-2009-Checklist-MS-Word for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

Author_response_1 – Supplemental material for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies

Supplemental material, Author_response_1 for Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies by Fengyuan Li, Rulan Yin and Qiang Guo in Therapeutic Advances in Respiratory Disease</p

Additional file 2: of Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis

Summaries of symptom thresholds required for diagnosis of depression/anxiety. (DOCX 19 kb

Additional file 1: of Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis

Search Terms. (DOCX 10 kb

Additional file 4: of Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis

Quality Assessment. (DOCX 19 kb

Data_Sheet_1_The Relationship Between Successful Aging and All-Cause Mortality Risk in Older Adults: A Systematic Review and Meta-Analysis of Cohort Studies.DOC

BackgroundThis meta-analysis aimed to explore the effect of successful aging (SA) on all-cause mortality risk in older people to provide a theoretical basis for promoting SA.MethodsPubMed, Embase, CINAHL, CNKI, and WanFang databases (inception to March 4, 2021) were searched for cohort studies to evaluate the relationship between SA and mortality in older people. A random-effects model was used to synthesis hazard ratio and 95% confidence intervals. Quality assessment was performed using the Newcastle–Ottawa scale. All statistical analyses were conducted in STATA 16.0.ResultsIn total, 21,158 older adults from 10 studies were included in the current systematic review and meta-analysis. The SA group tended to have 50% lower risk of all-cause mortality than the non-SA group (pooled hazard ratio = 0.50, 95% confidence intervals: 0.35–0.65, P 2 = 58.3%). The risk of all-cause mortality in older people increased by 17% for each unit increment in the healthy aging index (HAI) (I2 = 0%, P = 0.964). Compared with the reference group (HAI 0-2), older people with HAI 3-4, HAI 5-6, and HAI 7-10 had 1.31-fold, 1.73-fold, and 2.58-fold greater risk of all-cause mortality, respectively. Subgroup analysis did not reveal possible sources of heterogeneity.ConclusionsThis meta-analysis suggests that older adults with SA reduced the risk of all-cause mortality by 50%. However, few interventional studies have been conducted. Therefore, healthcare providers must be aware of the relationship between SA and mortality risk and actively develop intervention methods for helping old people achieve SA.</p